Jim Cramer Discusses These 13 Stocks & Criticizes Billionaires

Page 3 of 12

10. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders In Q4 2024: 98

Johnson & Johnson (NYSE:JNJ) is one of the biggest pharmaceutical companies in the world. Its heft has enabled the stock to endure despite a multi-billion dollar lawsuit that the firm will take years to settle. Johnson & Johnson (NYSE:JNJ)’s shares are up by a modest 3% over the year as they have benefited from a 14.6% year-to-date gain. The stock gained 4% in January after the firm’s fourth-quarter results saw it post $22.5 billion in revenue and $2.04 in earnings per share to beat analyst estimates. In his previous remarks, Cramer shared that Johnson & Johnson (NYSE:JNJ)’s shares tend to drive the entire sector up. Here are his latest comments:

“JNJ, which had just been, bedraggled down to 140s, has been a horse.”

Page 3 of 12